No evidence suggests the UK government’s COVID-19 testing contracts with a health company were awarded improperly, but the audit trail was inadequately maintained, a watchdog has found.
The National Audit Office (NAO) on Thursday published the result of its investigation into the government’s COVID-19 contracts with Randox Laboratories Ltd.
